Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Vaccine Immunol ; 16(9): 1374-7, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19641097

ABSTRACT

A total of 2,570 apparently healthy human immunodeficiency virus-negative adults from the six geopolitical zones in the country were enrolled in our study in 2006. The samples were assayed using the Cyflow technique. Data were analyzed using the Statistical Package for Social Scientists (SPSS). The majority (64%) of the participants had CD4 counts within the range of 501 to 1,000 cells/microl. The reference range for CD4 was 365 to 1,571 cells/microl, while the reference range for CD8 was 145 to 884 cells/microl.


Subject(s)
Leukocyte Count , Lymphocyte Subsets/immunology , Adolescent , Adult , Aged , Aged, 80 and over , CD4 Lymphocyte Count , CD4-CD8 Ratio , Female , Humans , Male , Middle Aged , Reference Values , Young Adult
2.
J Virol Methods ; 87(1-2): 63-70, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10856753

ABSTRACT

Glycoprotein G of HSV-2 (gG2) and a peptide, corresponding to a previously recognised immunodominant epitope spanning residues 561-578 of the protein, were compared directly for type-specific serodiagnosis of HSV-2. The protein was affinity purified and obtained in a commercially available EIA kit while the peptide, previously designated as peptide 55, was made as a multiple antigenic peptide. A panel of 100 characterised serum samples (60 HSV-2 positive, 20 HSV-1 positive and 20 HSV negative) was screened using the two antigens. The intact protein and peptide 55 showed the same sensitivity for antibodies in the serum of HSV-2 infected individuals, reacting with 96.7% (58/60) of the samples. The peptide did not react with any of the HSV-1 positive or HSV negative sera. In contrast, gG2 gave a number of false positive results, reacting with 20% (4/20) of the HSV-1 positive sera and 10% (2/20) of the HSV negative sera. The superior performance of peptide 55, together with the very much lower costs of its production, compared with gG2 suggest that the peptide will become the antigen of choice in enzyme immunoassays for type-specific serodiagnosis of HSV-2.


Subject(s)
Antibodies, Viral/blood , Enzyme-Linked Immunosorbent Assay/methods , Herpesvirus 2, Human/immunology , Immunoglobulin G/blood , Antigens, Viral/immunology , Cross Reactions/immunology , False Positive Reactions , Glycoproteins/immunology , Herpes Simplex/virology , Humans , Immunodominant Epitopes/immunology , Sensitivity and Specificity , Serologic Tests
3.
J Virol Methods ; 84(2): 169-73, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10680966

ABSTRACT

Evaluation was made of three enzyme-linked immunosorbent assay (ELISA) formats; varicella-zoster virus (VZV) indirect ELISA; VZV IgM capture using biotin and VZV IgM capture using peroxidase, for the detection of VZV-specific IgM antibodies in human sera. It was observed that there was no significant difference in sensitivity of detection using the three formats but there were important practical differences in the number of steps and hence time for assay completion between the three assay formats. All assays showed some cross-reactivity with sera containing anti-HSV1 antibodies.


Subject(s)
Antibodies, Viral/blood , Chickenpox/diagnosis , Enzyme-Linked Immunosorbent Assay/methods , Herpes Zoster/diagnosis , Herpesvirus 3, Human/immunology , Immunoglobulin M/blood , Antibody Specificity , Biotin/metabolism , Chickenpox/virology , Herpes Zoster/virology , Humans , Peroxidase/metabolism , Serologic Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...